FE

Fermi Inc.

FRMI | US

Overview

Corporate Details

ISIN(s):
US3149111086
LEI:
529900TSHBYBCFMYZ228
Country:
United States of America
Address:
N/A
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

No description available.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-01 13:10
Environmental & Social Information
Fermi and MVM EGI Announce Hybrid Cooling MOU
English 13.9 KB
2025-11-25 08:20
Capital/Financing Update
Response to Speculation
English 10.1 KB
2025-11-13 08:25
Report Publication Announcement
Publication of Fermi Inc. Interim Financial Report
English 10.3 KB
2025-11-11 08:25
Report Publication Announcement
Fermi Posts Third Quarter 2025 Shareholder Letter
English 13.6 KB
2025-11-06 08:25
Regulatory Filings
Advance in Aid of Construction Agreement
English 10.3 KB
2025-11-05 08:25
Report Publication Announcement
Notice of Inaugural Earnings Call
English 13.9 KB
2025-11-04 08:30
Environmental & Social Information
State of Texas Preliminary Approval for First 6GW
English 19.6 KB
2025-10-30 08:00
Regulatory Filings
Partnerships Announcement
English 14.9 KB

Automate Your Workflow. Get a real-time feed of all Fermi Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Fermi Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Fermi Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Metagenomi, Inc. Logo
Discovering novel gene editing tools from nature for curative genetic medicines.
United States of America
MGX
MindWalk Holdings Corp. Logo
AI-powered biotherapeutics firm offering end-to-end antibody discovery and engineering services.
United States of America
HYFT
Mips Logo
Licenses patented helmet technology to reduce rotational impact injuries in sports and construction.
Sweden
MIPS
A think tank providing research, consulting, and ICT solutions to public & private sectors.
Japan
3636
Modus Therapeutics Holding AB Logo
Developing sevuparin, a polysaccharide for sepsis, septic shock, and chronic inflammation.
Sweden
MODTX
Molecure S.A. Logo
Develops first-in-class small molecule drugs for oncology and inflammatory/fibrotic diseases.
Poland
MOC
Monopar Therapeutics Logo
Clinical-stage biotech developing radiopharmaceuticals for oncology and therapies for rare diseases.
United States of America
MNPR
Mural Oncology PLC Logo
Clinical-stage company developing cytokine immunotherapies for hard-to-treat solid tumors.
Ireland
MURA
N4 PHARMA PLC Logo
Developing a nanoparticle delivery system for advanced gene and vaccine therapies.
United Kingdom
N4P
NanoGroup S.A. Logo
Develops patented nanotechnology for oncology and transplantology diagnostics and therapies.
Poland
NNG

Talk to a Data Expert

Have a question? We'll get back to you promptly.